EP03.06. Synthetic Lethality Targeting Programmed Cell Death Reverses the Osimertinib Resistance Induced by ARID1A Deficiency in LUAD - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Dantong Sun
Meta Tag
Speaker Dantong Sun
Topic Tumor Biology: Translational Biology - Translational Therapeutics
lung adenocarcinoma
ARID1A deficiency
targeted therapy
tumorigenic ability
osimertinib resistance
EZH2/E2F1/PTEN axis
programmed cell death
therapeutic strategies
Powered By